MedPath

Hexaxim Suspension for Injection

Registration Number: MAL13075068ARZ

Approved
Approval ID

abfa94fae3122dc6

Registration Number

MAL13075068ARZ

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types3 types
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (3)

1units UnitsAvailable
Package Size: 1units Units
Status: NPRA Approved
10units UnitsAvailable
Package Size: 10units Units
Status: NPRA Approved
10vial VialsAvailable
Package Size: 10vial Vials
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (7)

Filamentous haemagglutin ( FHA )Active
Monograph: filamentous haemagglutin ( fha )
Pertussis Toxoid ( PT)Active
Monograph: pertussis toxoid ( pt)
poliomyelitis, trivalent, inactivated, whole virusActive
Monograph: poliomyelitis, trivalent, inactivated, whole virus
Haemophilus Influenza Type b ConjugateActive
Monograph: haemophilus influenza type b conjugate
Hepatitis B surface antigen purifiedActive
Monograph: hepatitis b surface antigen purified
Diphtheria ToxoidActive
Monograph: 白喉类毒素
Tetanus ToxoidActive

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hexaxim Suspension for Injection - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform